FPH Announces New Future Director Appointment

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

Fisher & Paykel Healthcare Announces New Future Director Appointment

Auckland, New Zealand, 5 October 2023 – Fisher & Paykel Healthcare Corporation Limited announced
today that it has selected Charlotte Walshe to participate in the Future Directors programme, with effect
from 1 January 2024.

Ms Walshe has more than 20 years of experience across a range of sectors. This includes regulated
global markets (healthcare, finance), high-tech manufacturing, export, technology and research institutes.
Ms Walshe has also held chief executive roles with Jade Software Corporation and medical device
manufacturer and health informatics provider Dynamic Controls, and she has been a director and trustee
of a number of government organisations, private companies and research institutions.

She received a master of science in physics from the University of Canterbury, a bachelor of science
(BSc) majoring in physics and mathematics, also from the University of Canterbury, and an
Entrepreneurship Development Programme certificate from the Massachusetts Institute of Technology.

Future Directors is an initiative of the Institute of Directors aimed at giving talented executives exposure
to a company board to gain governance skills and experience for a 12-to-18-month period. Future
Directors attend board meetings to observe and participate in discussions, but they do not have voting
rights.

"Charlotte’s experience and dynamism will be valuable assets," said Scott St John, Board Chair. "She
has demonstrated leadership and expertise in both public and private sectors in R&D and highly
regulated environments. I'm pleased to have the opportunity to work with her."

Ms Walshe said, “Fisher & Paykel Healthcare is an inspiring high-tech medical device company with
global presence and recognition. I’m excited to learn from the Board, grow my governance skills and
share my own insights.”

Fisher & Paykel Healthcare’s current Future Director, Tracey Barron, is completing her term with the
company on 1 December 2023.

"We want to thank Ms Barron for her contribution to the Board, and we wish her all the best for the
future,” said Mr St John.

Mr St John commended the Future Directors programme as a mutually beneficial initiative. "It allows the
Board to benefit from new perspectives while giving the emerging directors an opportunity to develop
their governance competencies. We are delighted to keep supporting it."


About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for
use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The
company’s products are sold in over 120 countries worldwide. For more information about the company,
visit our website www.fphcare.com.

ENDS

Media & Investor Contacts:

Hayden Brown
Head of Capital Markets and Investor Relations
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 (0) 21 713 911


Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board Chair.